Navigation Links
Vestiage Signs Buyside Engagement Agreement with CJK Securities
Date:4/29/2013

Newport Beach, California (PRWEB) April 29, 2013

Vestiage Inc, a publicly traded anti-aging lifestyle company focused on science-based, highly effective premium branded cosmeceuticals and nutraceuticals, announced today that it has signed a buyside agreement with CJK Securities to accelerate the Company's Acquisition Initiative.

"I have known CJK for some time now and they have a fantastic ability to know what we're looking for and to find assets that nobody else knows about that fit our Acquisition Initiative and our niche well", said Scott Kimball, CEO of Vestiage. "They also know our philosophy and Vestiage well. They are highly responsive and professional. Working with them has always been easy and a pleasure for us."

For more information on the Vestiage Acquisition Initiative, please visit the Company website.

About Vestiage
Vestiage is a leading publicly traded anti-aging lifestyle company offering premium branded science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the use of human stem cell, marine/ocean based and patented botanically-based ingredients and science to produce potent and effective products using clinically proven ingredients. Using high potency and novel ingredient combinations allows Vestiage to offer highly effective cosmeceuticals such as Reluma, and multifunctional nutraceuticals through Monterey Bay Nutraceuticals. Vestiage brands address the top “in demand” anti-aging consumer concerns. To learn more, visit the Company website.

About CJK Securities
CJK Securities, Inc. is a licensed broker-dealer member of FINRA that provides financial advisory services to Middle Market companies whether owned by a family, several investors, or by a venture capital or private equity firm. During their careers, the CJK team has completed over $2 billion of sell-side, buy-side and capital formation transactions. CJK provides focused, personalized and responsive service while working closely with our clients' personnel to bring transactions to a successful close. For more information, visit http://www.CJKsecurities.com.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10640048.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Vestiage Announces Key Partners for Launch of Monterey Bay Nutraceuticals Anti-Aging Wellness Products
2. Vestiage Announces Filing of Disclosure Statement with Exchange
3. Vestiage CEO Comments on Immortal Life
4. Vestiage to Partner with Skincare By Alana
5. Vertilon Signs Crisel Instruments as its Distributor in Italy
6. Bausch + Lomb Signs Exclusive License Agreement with Paragon BioTeck for Phenylephrine
7. Entertainment Agency and Speaker Bureau Mark Sonder Productions Signs the Health & Wellness Shaman, Robert Cohen, PhD, LPC, DCEP for Meetings and Events Worldwide
8. Samsung Thales signs Development Agreement with Novelda
9. Eddie Leong Signs on as Advisory Board Member and Compliance Officer for Grace Century, International Research and Private Equity Consultant
10. Algae.Tec Signs MOU with WorleyParsons for Global Project Development Program
11. Quadrant Engineering Plastic Products Assigns Production of Acetron® GP and Nylon 101 Hex/Square Rods to Atlas Fibre Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer experts from ... believe could be a new and helpful biomarker for malignant pleural mesothelioma. Surviving ... to read it now. , Biomarkers are components in the blood, tissue ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... on a range of subjects including policies, debt and investment ... Speaking at a lecture to the Canadian Economics ... the country,s inflation target, which is set by both the ... "In certain areas there needs to be frequent ... not sit down and address strategy together?" He ...
Breaking Biology Technology:
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
Breaking Biology News(10 mins):